Bamco Inc. NY Sells 1,200 Shares of McKesson Corporation $MCK

Bamco Inc. NY lessened its stake in shares of McKesson Corporation (NYSE:MCK) by 18.5% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,300 shares of the company’s stock after selling 1,200 shares during the period. Bamco Inc. NY’s holdings in McKesson were worth $4,094,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. GGM Financials LLC purchased a new position in shares of McKesson in the third quarter worth $25,000. State of Wyoming bought a new position in shares of McKesson during the second quarter valued at $29,000. Hopwood Financial Services Inc. purchased a new stake in shares of McKesson during the third quarter valued at $31,000. Delos Wealth Advisors LLC bought a new stake in McKesson in the 2nd quarter worth about $35,000. Finally, Abound Wealth Management increased its holdings in McKesson by 104.3% in the 3rd quarter. Abound Wealth Management now owns 47 shares of the company’s stock worth $37,000 after buying an additional 24 shares in the last quarter. Hedge funds and other institutional investors own 85.07% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on MCK shares. Morgan Stanley restated an “overweight” rating and set a $966.00 target price on shares of McKesson in a research note on Thursday, January 29th. Robert W. Baird set a $968.00 price objective on shares of McKesson in a report on Wednesday, January 14th. Wall Street Zen downgraded shares of McKesson from a “buy” rating to a “hold” rating in a research report on Saturday. Leerink Partners restated an “outperform” rating and issued a $1,085.00 target price on shares of McKesson in a report on Thursday, March 5th. Finally, TD Cowen lifted their target price on shares of McKesson from $1,000.00 to $1,012.00 and gave the stock a “buy” rating in a research report on Thursday, February 5th. Thirteen analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat.com, McKesson currently has a consensus rating of “Moderate Buy” and an average target price of $960.93.

Insider Buying and Selling

In other McKesson news, EVP Leann B. Smith sold 190 shares of the company’s stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an average price of $945.00, for a total value of $179,550.00. Following the completion of the transaction, the executive vice president directly owned 2,989 shares in the company, valued at $2,824,605. This represents a 5.98% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $955.00, for a total transaction of $313,240.00. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 3,868 shares of company stock worth $3,743,820 in the last quarter. 0.08% of the stock is owned by insiders.

McKesson Stock Performance

Shares of McKesson stock opened at $943.43 on Tuesday. McKesson Corporation has a fifty-two week low of $637.00 and a fifty-two week high of $999.00. The company has a market capitalization of $115.56 billion, a P/E ratio of 27.13, a P/E/G ratio of 1.51 and a beta of 0.38. The company has a fifty day moving average of $896.29 and a 200 day moving average of $828.19.

McKesson (NYSE:MCK) last posted its quarterly earnings results on Wednesday, February 4th. The company reported $9.34 EPS for the quarter, beating analysts’ consensus estimates of $9.19 by $0.15. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The business had revenue of $106.16 billion for the quarter, compared to analysts’ expectations of $105.98 billion. During the same period last year, the firm earned $8.03 earnings per share. The business’s quarterly revenue was up 11.4% on a year-over-year basis. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. Analysts forecast that McKesson Corporation will post 32.77 EPS for the current year.

McKesson Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 1st. Investors of record on Monday, March 2nd will be paid a dividend of $0.82 per share. This represents a $3.28 annualized dividend and a yield of 0.3%. The ex-dividend date of this dividend is Monday, March 2nd. McKesson’s dividend payout ratio (DPR) is 9.43%.

McKesson Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.